Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ACLP Activates Cancer-Associated Fibroblasts and Inhibits CD8+ T-Cell Infiltration in Oral Squamous Cell Carcinoma.
Sekiguchi S, Yorozu A, Okazaki F, Niinuma T, Takasawa A, Yamamoto E, Kitajima H, Kubo T, Hatanaka Y, Nishiyama K, Ogi K, Dehari H, Kondo A, Kurose M, Obata K, Kakiuchi A, Kai M, Hirohashi Y, Torigoe T, Kojima T, Osanai M, Takano K, Miyazaki A, Suzuki H. Sekiguchi S, et al. Among authors: hirohashi y. Cancers (Basel). 2023 Aug 28;15(17):4303. doi: 10.3390/cancers15174303. Cancers (Basel). 2023. PMID: 37686580 Free PMC article.
Human CD8 and CD4 T cell epitopes of epithelial cancer antigens.
Sato N, Nabeta Y, Kondo H, Sahara H, Hirohashi Y, Kashiwagi K, Kanaseki T, Sato Y, Rong S, Hirai I, Kamiguchi K, Tamura Y, Matsuura A, Takahashi S, Torigoe T, Ikeda H. Sato N, et al. Among authors: hirohashi y. Cancer Chemother Pharmacol. 2000;46 Suppl:S86-90. doi: 10.1007/pl00014057. Cancer Chemother Pharmacol. 2000. PMID: 10950155
Identification of human antitumor cytotoxic T lymphocytes epitopes of recoverin, a cancer-associated retinopathy antigen, possibly related with a better prognosis in a paraneoplastic syndrome.
Maeda A, Ohguro H, Nabeta Y, Hirohashi Y, Sahara H, Maeda T, Wada Y, Sato T, Yun C, Nishimura Y, Torigoe T, Kuroki Y, Sato N. Maeda A, et al. Among authors: hirohashi y. Eur J Immunol. 2001 Feb;31(2):563-72. doi: 10.1002/1521-4141(200102)31:2<563::aid-immu563>3.0.co;2-d. Eur J Immunol. 2001. PMID: 11180121 Free article.
Natural antigenic peptides from squamous cell carcinoma recognized by autologous HLA-DR8-restricted CD4+ T cells.
Kondo H, Sahara H, Miyazaki A, Nabeta Y, Hirohashi Y, Kanaseki T, Yamaguchi A, Yamada N, Hirayama K, Suzuki M, Hamuro J, Torigoe T, Takahashi N, Kohama GI, Ikeda H, Sato N. Kondo H, et al. Among authors: hirohashi y. Jpn J Cancer Res. 2002 Aug;93(8):917-24. doi: 10.1111/j.1349-7006.2002.tb01338.x. Jpn J Cancer Res. 2002. PMID: 12716470 Free PMC article.
A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins.
Idenoue S, Hirohashi Y, Torigoe T, Sato Y, Tamura Y, Hariu H, Yamamoto M, Kurotaki T, Tsuruma T, Asanuma H, Kanaseki T, Ikeda H, Kashiwagi K, Okazaki M, Sasaki K, Sato T, Ohmura T, Hata F, Yamaguchi K, Hirata K, Sato N. Idenoue S, et al. Among authors: hirohashi y. Clin Cancer Res. 2005 Feb 15;11(4):1474-82. doi: 10.1158/1078-0432.CCR-03-0817. Clin Cancer Res. 2005. PMID: 15746049
254 results